Provention Bio - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsProvention Bio

Provention Bio(PRVB)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Tzield	Teplizumab	2022-11-17		Type 1 diabetes mellitus

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

colorectal neoplasms

,

pancreatic neoplasms

,

,

cholangiocarcinoma

prostatic neoplasms

,

,

alzheimer disease

,

cognitive dysfunction

,

non-hodgkin lymphoma

,

,

hodgkin disease

,

,

,

myeloid leukemia acute

,

myeloid leukemia

,

rheumatoid arthritis

,

Globulin, immune

healthy volunteers/patients

,

,

hodgkin disease

,

squamous cell neoplasms

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

hematologic neoplasms

,

alzheimer disease

,

,

,

urologic neoplasms

,

transitional cell carcinoma

,

,

triple negative breast neoplasms

,

,

pancreatic neoplasms

,

small cell lung carcinoma

,

squamous cell carcinoma

,

prostatic neoplasms

,

fallopian tube neoplasms

,

pancreatic ductal carcinoma

,

rheumatoid arthritis

,

uterine cervical neoplasms

,

b-cell lymphoma marginal zone

,

waldenstrom macroglobulinemia

,

multiple myeloma

,

brain neoplasms

,

lymphoid leukemia

,

,

rectal neoplasms

,

esophageal squamous cell carcinoma

,

cholangiocarcinoma

,

,

serous cystadenocarcinoma

,

hereditary breast and ovarian cancer syndrome

,

diabetes mellitus

,

type 1 diabetes mellitus

,

insulin resistance

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

ulcerative colitis

,

,

,

small cell carcinoma

,

castration-resistant prostatic neoplasms

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

epstein-barr virus infections

,

oropharyngeal neoplasms

,

,

,

peripheral nervous system diseases

,

,

residual neoplasm

,

adenocarcinoma of lung

,

precursor cell lymphoblastic leukemia-lymphoma

,

biphenotypic leukemia acute

,

burkitt lymphoma

,

merkel cell carcinoma

,

clostridium infections

,

colonic neoplasms

,

non-small-cell lung carcinoma

,

,

colorectal neoplasms

,

neoplasm metastasis

,

,

ovarian neoplasms

,

stomach neoplasms

,

,

squamous cell carcinoma of head and neck

,

non-hodgkin lymphoma

,

,

b-cell lymphoma

,

hepatocellular carcinoma

,

liver neoplasms

,

endometrial neoplasms

,

,

large b-cell lymphoma diffuse

,

mantle-cell lymphoma

,

renal cell carcinoma

,

urinary bladder neoplasms

,

biliary tract neoplasms

,

head and neck neoplasms

,

,

follicular lymphoma

,

esophageal neoplasms

,

malignant mesothelioma

,

,

respiratory syncytial virus infections

,

,

uterine neoplasms

,

,

,

,

gastrointestinal neoplasms

,

respiratory tract infections

,

lymphoproliferative disorders

,

kidney neoplasms

,

laryngeal diseases

,

breast diseases

,

type 2 diabetes mellitus

,

,

inflammatory bowel diseases

,

,

human influenza

,

eosinophilic esophagitis

,

,

,

gastroenteritis

,

coronavirus infections

,

,

hematologic diseases

,

hypereosinophilic syndrome

,

leukocyte disorders

,

exercise-induced asthma

,

neuromyelitis optica

,

gallbladder neoplasms

,

breast neoplasms

,

,

systemic lupus erythematosus

,

b-cell chronic lymphocytic leukemia

,

ovarian epithelial carcinoma

,

b-cell leukemia

,

lymphatic diseases

,

pulmonary eosinophilia

,

,

immunologic deficiency syndromes

,

,

,

respiratory syncytial viruses

,

female genital neoplasms

,

myasthenia gravis

healthy volunteers/patients

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use